Skip to main content

Table 1 Clinicopathological features of KCNMA1 promoter methylation in 112 patients with GC

From: KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome

Factors

Methylated (N = 77)

Non-methylated (N = 35)

P value

Age (mean ± SD)

64.44 ± 1.00

61.81 ± 1.86

0.182

Gender

 Male

50

22

0.879

 Female

27

13

 

Tumor sizes

  ≤ 5 cm

35

26

0.005

  > 5 cm

42

9

 

Depth of invasion

 T1+ T2

17

2

0.032

 T3+ T4

60

33

 

Lymphnode metastasis

 N0

22

7

0.808

 N1

23

12

 

 N2

17

9

 

 N3

15

7

 

Metastasis

 M0

67

29

0.560

 M1

10

6

 

TNM stages

 I

9

2

0.687

 II

19

11

 

 III

38

16

 

 IV

11

6

 
  1. The entries in bold showed the P value is less than 0.05
Back to article page

Molecular Cancer

ISSN: 1476-4598